http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H11504912-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D477-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D477-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D477-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D477-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D477-00 |
| filingDate | 1996-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1999-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H11504912-A |
| titleOfInvention | Carbapenem esters |
| abstract | (57) Abstract: Formula (I) [wherein, R may be a is (are here R alpha hydrogen, optionally substituted (C 1 to 6) is an alkyl or substituted (a) aryl; R beta is hydrogen, optionally substituted be a (C 1 to 6) alkyl or optionally substituted aryl; or the R alpha and R beta together, further heteroatom R 1 is unsubstituted or a fluoro, hydroxy group (protected by an easily removable hydroxy protecting group, with or without the formation of an optionally substituted 5- or 6-membered heterocyclic ring) is located is substituted (in C 1 to 6) alkyl- may optionally be) or amino group (which may be protected by an amino protecting group which can be easily removed); R 2 is hydrogen or methyl; R 3 is, (a Formula (i) (wherein, R 1 is hydrogen or (C 1 to 6) alkyl, R 2 is hydrogen, optionally substituted by halogen (C 1 to 6) alkyl, (C 1 to 6) alkenyl, (C 1 to 6) alkoxycarbonyl, aryl or heteroaryl,, R 3 is (a) hydrogen, (C 1 to 6) alkyl or (C 1 to 6) alkoxycarbonyl,, R 4 groups, and (b) formula CH (in R a) OCOR b (wherein, R a is hydrogen, (C 1 to 6) shown in a pharmaceutically acceptable ester forming groups) alkyl, (C 3 ~ 7) cycloalkyl, methyl, or phenyl, and R b at (C 1 to 6) alkyl (C 3 to 7-) a cycloalkyloxy or (C 1 to 6) alkoxy (C 1 to 6) alkyl) Selected from the group consisting of the groups shown below] Useful in treating bacterial infections. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007039383-A |
| priorityDate | 1995-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 131.